|
1
|
Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.
|
J Clin Oncol
|
2012
|
3.68
|
|
2
|
Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.
|
J Hepatol
|
2009
|
2.84
|
|
3
|
Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.
|
Ann Surg
|
2007
|
2.53
|
|
4
|
Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial.
|
J Natl Cancer Inst
|
2012
|
2.10
|
|
5
|
Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study.
|
Ann Surg Oncol
|
2010
|
2.00
|
|
6
|
Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial.
|
Radiology
|
2007
|
1.75
|
|
7
|
Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells.
|
Hepatology
|
2010
|
1.69
|
|
8
|
Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.
|
J Vasc Interv Radiol
|
2011
|
1.46
|
|
9
|
Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
|
Cancer
|
2012
|
1.38
|
|
10
|
Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
|
Radiology
|
2012
|
1.24
|
|
11
|
Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis.
|
Radiology
|
2011
|
1.08
|
|
12
|
Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study.
|
Ann Surg Oncol
|
2008
|
1.08
|
|
13
|
Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
|
Radiology
|
2011
|
1.08
|
|
14
|
The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
|
Ann Surg Oncol
|
2013
|
1.07
|
|
15
|
Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.
|
Biomaterials
|
2011
|
0.98
|
|
16
|
Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China.
|
World J Gastroenterol
|
2010
|
0.96
|
|
17
|
Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
|
Surg Oncol
|
2007
|
0.96
|
|
18
|
Single nucleotide polymorphism of rs430397 in the fifth intron of GRP78 gene and clinical relevance of primary hepatocellular carcinoma in Han Chinese: risk and prognosis.
|
Int J Cancer
|
2009
|
0.94
|
|
19
|
Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma.
|
Chin J Cancer
|
2012
|
0.92
|
|
20
|
Targeted drug delivery systems mediated by a novel Peptide in breast cancer therapy and imaging.
|
PLoS One
|
2013
|
0.88
|
|
21
|
Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma.
|
J Gastroenterol Hepatol
|
2011
|
0.87
|
|
22
|
Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review.
|
Chin J Cancer
|
2013
|
0.86
|
|
23
|
Radiofrequency ablation versus open hepatic resection for elderly patients (> 65 years) with very early or early hepatocellular carcinoma.
|
Cancer
|
2013
|
0.84
|
|
24
|
Preoperative levels of serum interleukin-6 in patients with hepatocellular carcinoma.
|
Hepatogastroenterology
|
2011
|
0.84
|
|
25
|
[Prophylaxis and clinical treatment for surgical margin recurrence of small primary hepatocellular carcinoma].
|
Ai Zheng
|
2005
|
0.83
|
|
26
|
[Osteopontin as a potential biomarker of metastasis and recurrence for hepatocellular carcinoma].
|
Ai Zheng
|
2006
|
0.81
|
|
27
|
Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma.
|
Oncology
|
2013
|
0.80
|
|
28
|
Phosphorylation at tyrosine 114 of Proliferating Cell Nuclear Antigen (PCNA) is required for adipogenesis in response to high fat diet.
|
Biochem Biophys Res Commun
|
2012
|
0.80
|
|
29
|
[Correlation of preoperative neutrophil-to-lymphocyte ratio to prognosis of young patients with hepatocellular carcinoma].
|
Ai Zheng
|
2009
|
0.79
|
|
30
|
[Efficacy of pulmonary resection for primary hepatocellular carcinoma patients with pulmonary metastasis].
|
Ai Zheng
|
2008
|
0.78
|
|
31
|
Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
|
J Cancer Res Clin Oncol
|
2014
|
0.78
|
|
32
|
Radiofrequency ablation does not induce the significant increase of CD4(+) CD25(+) Foxp3(+) regulatory T cells compared with surgical resection in Hepal-6 tumor model.
|
Arch Immunol Ther Exp (Warsz)
|
2013
|
0.77
|
|
33
|
[Inhibitory effects of human AFP-derived peptide-pulsed dendritic cells on mouse hepatocellular carcinoma].
|
Ai Zheng
|
2008
|
0.77
|
|
34
|
[Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure].
|
Ai Zheng
|
2005
|
0.77
|
|
35
|
[Comparison of shaft temperature related treatment efficacy between "air-cooled" microwave coagulation and traditional microwave coagulation].
|
Ai Zheng
|
2004
|
0.76
|
|
36
|
Role of radiofrequency ablation in the treatment of small hepatocellular carcinoma.
|
World J Hepatol
|
2010
|
0.75
|
|
37
|
Reply to D.H. Palmer.
|
J Clin Oncol
|
2013
|
0.75
|
|
38
|
[Acute toxicity of carbon-coated iron nanocrystal and its effect on liver and kidney functions and hematological system].
|
Nan Fang Yi Ke Da Xue Xue Bao
|
2007
|
0.75
|
|
39
|
[Clinical treatment of small hepatocellular carcinoma].
|
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
|
2006
|
0.75
|
|
40
|
Conformal radiofrequency ablation of hepatocellular carcinoma with a multi-pin bipolar system.
|
J Surg Oncol
|
2011
|
0.75
|
|
41
|
[Analysis of the therapeutic efficiency of percutaneous radiofrequency ablation on hepatocellular carcinomas].
|
Zhonghua Gan Zang Bing Za Zhi
|
2004
|
0.75
|
|
42
|
[Application of total intravenous anesthesia with remifentanyl and propofol to radiofrequency ablation].
|
Ai Zheng
|
2007
|
0.75
|
|
43
|
[Clinicopathologic features and treatment outcomes of primary hepatic lymphoma: a report of four cases].
|
Ai Zheng
|
2005
|
0.75
|
|
44
|
A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol.
|
Expert Opin Biol Ther
|
2015
|
0.75
|
|
45
|
Efficacy of combining temperature- and power-controlled radiofrequency ablation for malignant liver tumors.
|
Chin J Cancer
|
2010
|
0.75
|
|
46
|
[Efficacy of hepatectomy-predominant treatment on stage III A hepatocellular carcinoma: a report of 108 cases].
|
Ai Zheng
|
2009
|
0.75
|
|
47
|
[Preliminary study on orthotopic liver transplantation for treatment of advanced hepatocellular carcinoma without extra-hepatic metastasis - a report of 10 cases].
|
Ai Zheng
|
2004
|
0.75
|
|
48
|
[Radiofrequency ablation combined with ethanol injection for liver cancer treatment---an experimental study].
|
Ai Zheng
|
2006
|
0.75
|
|
49
|
[Sonographically guided percutaneous "air-cooled" microwave coagulation in live pig liver: an experimental study].
|
Ai Zheng
|
2004
|
0.75
|
|
50
|
[Experimental study on optimal operating parameters setting of radiofrequency thermal ablation in normal ex-swine livers].
|
Ai Zheng
|
2005
|
0.75
|